Drug intelligence / Profile preview

Tricalgoxyl

Development stage: Unknown
Lead developer: Foltène Pharma
Administration: Topical

Overview

Tricalgoxyl is a patented, exclusive cosmetic active ingredient developed by Foltène Pharma, consisting of a mixture of sulfated polysaccharides extracted from brown algae, specifically *Fucus Vesiculosus* and *Ascophyllum Nodosum*. Harvested from the UNESCO Natural Reserve in Brittany, France, this topical agent is designed to treat hair loss and thinning by revitalizing the scalp and strengthening the hair fiber. It works by normalizing the hair's life cycle, thereby reducing the falling phase and encouraging natural growth. Tricalgoxyl is incorporated into various dermocosmetic hair care formulations, including shampoos and scalp treatments, to restore the natural physiological balance of the scalp and promote thicker, healthier hair.

Brand names: Foltène
Other names: Tricalgoxyl

Beyond the preview

Go deeper on Tricalgoxyl.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tricalgoxyl.

Explore the full profile